Maze Therapeutics, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
MAZE on Nasdaq
Location
South San Francisco, CA
Fiscal year end
31 December
Latest financial report
25 Mar 2026

Quick Takeaways

  • MAZE - Maze Therapeutics, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2025.
  • Headline metric: Return On Equity -599%.

What Changed

  • Return On Equity YoY change: <span class="text-green-600">+3828%</span>.
  • Most recent SEC facts end date: 31 Dec 2025.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2025-12-31) highlights Return On Equity -599.0%, Return On Assets -41.1%, and Current Ratio 15.5x.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

20.3/100

Weak Confidence medium

Return On Equity

-599%

Metric score 0.0/100

Return On Assets

-41%

Metric score 0.0/100

Financial Health

Current Ratio
15.5x
Debt to Equity
0.13x

Strengths

Debt-to-equity

Watchpoints

Return On Equity, Return On Assets, and Current Ratio

Key metrics snapshot

Return On Equity

-599%

YoY: +3828%

Industry median: -47% (n=217)

View history

Return On Assets

-41%

YoY: -289%

Industry median: -45% (n=216)

View history

Current Ratio

15.5x

YoY: +59%

Industry median: 3.67x (n=218)

View history

Debt-to-equity

0.13x

YoY:

Industry median: 0.28x (n=202)

View history

NetIncomeLoss YoY

-351%

YoY:

Industry median: -9.9% (n=211)

View history

Profitability

Metric Latest value YoY change
Return On Equity -599% +3828%
Return On Assets -41% -289%

Financial Health

Metric Latest value YoY change
Current Ratio 15.5x +59%
Debt-to-equity 0.13x

Growth

Metric Latest value YoY change
NetIncomeLoss YoY -351%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 48,119,444
Common Stock, Shares, Outstanding 49,335,551 +1916%
Common Stock, Value, Issued $49,000 +2350%
Weighted Average Number of Shares Outstanding, Basic 42,976,024 +1694%
Weighted Average Number of Shares Outstanding, Diluted 42,976,024 +1474%

Additional Metrics

Metric Latest value YoY change
Research and Development Expense $108,448,000 +30%
General and Administrative Expense $34,451,000 +30%
Operating Income (Loss) $142,899,000 -348%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $131,120,000 -346%
Earnings Per Share, Basic -3.05 -315%
Earnings Per Share, Diluted -3.05 -344%
Cash and Cash Equivalents, at Carrying Value $189,247,000 -3.8%
Marketable Securities, Current $152,670,000
Assets, Current $349,717,000 +73%
Property, Plant and Equipment, Net $5,044,000 -24%
Operating Lease, Right-of-Use Asset $20,116,000 -13%
Other Assets, Noncurrent $3,048,000 -61%
Assets $397,127,000 +65%
Accounts Payable, Current $1,794,000 -7.5%
Employee-related Liabilities, Current $10,853,000 +34%
Liabilities, Current $22,556,000 +9.1%
Operating Lease, Liability, Noncurrent $18,511,000 -16%
Other Liabilities, Noncurrent $1,094,000 +13%
Liabilities $42,161,000 -3.4%
Retained Earnings (Accumulated Deficit) $489,547,000 -37%
Stockholders' Equity Attributable to Parent $354,966,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $354,966,000
Liabilities and Equity $397,127,000 +65%
Common Stock, Shares Authorized 500,000,000 +22%
Common Stock, Shares, Issued 49,335,551 +1916%
Common Stock, Par or Stated Value Per Share 0.001 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $190,335,000 -3.8%
Deferred Tax Assets, Valuation Allowance $112,030,000 +27%
Operating Lease, Liability $23,306,000
Lessee, Operating Lease, Liability, to be Paid $28,137,000
Property, Plant and Equipment, Gross $24,255,000 +3.1%
Operating Lease, Liability, Current $4,795,000 +3.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two $5,622,000
Lessee, Operating Lease, Liability, to be Paid, Year One $4,982,000
Operating Lease, Weighted Average Discount Rate, Percent 0.08
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $4,831,000
Lessee, Operating Lease, Liability, to be Paid, Year Three $5,819,000
Unrecognized Tax Benefits $6,634,000 -2.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four $6,023,000
Additional Paid in Capital $844,354,000 +1687%
Deferred Tax Assets, Net of Valuation Allowance $116,286,000 +24%
Share-based Payment Arrangement, Expense $16,400,000 +70%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY